V2 Financial group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
V2 Financial group's BMY Position: Q2 2025 in Review
V2 Financial group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,300 shares — an estimated $201K sold.
V2 Financial group first reported a position in BMY in Q2 2024 and held it in 3 quarters. The position peaked at $233K in Q3 2024. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- V2 Financial group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- V2 Financial group sold 3,300 Bristol-Myers Squibb shares in Q2 2025, an estimated $201K.
- V2 Financial group first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 3 quarters.
- V2 Financial group's Bristol-Myers Squibb position peaked at $233K in Q3 2024.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on V2 Financial group's 13F filing for Q2 2025, filed 18 Aug 2025.